MaxVal Releases Max-IDS™ 4.0.2

MaxVal announces the latest upgrade to its information disclosure statement software, Max-IDS™, version 4.0.2. This new version includes multiple enhancements and new features, including: Enhanced, high-speed import process for citations and non-patent literature, which eliminates manual effort and thereby reduces data entry errors. New reference aging system helps avoid  Patent Term Adjustment (PTA) delays and supplemental IDS fees. Expanded authentication and integration capabilities simplify deployment, eliminate password complexity for users and enhances connectivity with docketing systems. Updated user-friendly dashboards, reports and alerts ensure users have quick, easy access to critical data needed to ensure timely filing of IDSs. “As a leader

Continue reading »

Hot Topics in Tech | September 2018 Newsletter | Maxval

This issue covers cardiovascular diseases and discloses the technological categories and products related to the use of renal denervation approach for managing hypertension. It also talks about the three main categories of Artificial Intelligence namely Artificial Narrow Intelligence (ANI), Artificial General Intelligence (AGI), and Artificial Super Intelligence (ASI). They influence human life in the form of automated cars, virtual assistants, image recognition software, robotics, games, life science and so on. Read more on this report.

Continue reading »

MaxVal Announces symphony® 1.5 – The Latest Version of Its Intellectual Property Management System

MaxVal announces the latest upgrade to its advanced, cloud-based IP management platform, symphony®. Since its launch in 2016, symphony® has revolutionized IP management through its innovative use of Salesforce.com’s Lightning platform, delivering the industry’s most advanced workflow and automation capabilities; all in a highly configurable, intuitive system, designed for the modern IP department. “MaxVal’s symphony® platform delivers a host of innovative and compelling operational capabilities to a yearning IP Management market,” said Eyal Iffergan, President of Hyperion Research, the industry’s leading analyst-based market research firm covering the IPM market. “Symphony harnesses the expansive Salesforce feature toolkit to achieve a robust end-to-end

Continue reading »

Hot Topics in Tech | August 2018 Newsletter | Maxval

In this issue, we have covered a couple of hot topics that are currently trending in the biotech and blockchain technology industries. We have highlighted Illumina’s Q2 results and provided some insights about the company alongwith a quick run-through of the firm’s recent collaborations in China. Illumina reported a revenue of $830 million in Q2 which is a 25% increase compared to $662 million in the same quarter of 2017. Illumina’s biggest advantage over its competitors lies in its technology diversification. We have also discussed about Walmart, who aims to venture into transportation and logistics markets through a methodology (recently filed for patent) by

Continue reading »

Hot Topics in Tech | June 2018 Newsletter | Maxval

In this issue, we have covered a couple of hot topics that are currently trending in the biotech and cloud-tech industries. We have talked about the FDA’s approval of tisagenlecleucel (KYMRIAH, Novartis Pharmaceuticals Corp.), a CD19-directed genetically modified autologous T-cell immunotherapy, to include treatment of patients with relapsed or refractory large B-cell lymphoma. Tisagenlecleucel is the only CAR T-cell therapy to receive FDA approval for two distinct indications. The report includes a chart of major commercial players in the CAR T-cell space and a Year-on-Year trend on the number of patents and patent applications from 2012 to 2018. We have

Continue reading »

Technology Landscape Study on CRISPR-Cas9

Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool. Increasing investment in this field is indicative of global market opportunities for CRISPR-Cas9 over existing alternatives. The objective of this study is to explore the market and patenting activity in CRISPR-Cas9 gene editing technology. This study considers issued patents and pending published applications related to CRISPR-Cas9 published since January 1, 2007. Search strategies using various combinations of keywords, classification codes, and prominent assignees resulted in more

Continue reading »

MaxVal to Sponsor and Exhibit at IPBC Global, San Francisco (June 10-12, 2018)

MaxVal is sponsoring the 11th annual event of IP Business Congress Global (IPBC), to be held from June 10-12, 2018 at Palace Hotel, San Francisco. IPBC is an established gathering for the World’s IP Business leaders ensuring extensive formal and informal networking opportunities. Its unrivaled coverage and in-depth analysis of key sectors provide executives critical business intelligence to maximize the IP value. As an exhibiting sponsor, MaxVal will demonstrate its end-to-end IP Management platform, Symphony, known for its robustness, reliability, and automation in handling the complete IP lifecycle. “I’m proud to be a part of the company that has created Symphony

Continue reading »

Recent advances in Diabetes Management | April 2018 Newsletter | MaxVal

The article addresses Medtronic’s recent FDA approval of the Guardian™ Connect Continuous Glucose Monitoring (CGM) system. A brief overview of all the clinical studies related to CGM has been presented. It also analyzes the recent findings on a microneedle system for non-invasive insulin delivery. A birds-eye view of patent filings related to microneedles for insulin delivery, with a focus on global players is presented.

Continue reading »

MaxVal Exhibits at INTA 140th Annual Meeting, Seattle, WA (May 19-23, 2018)

MaxVal is exhibiting at INTA 140th Annual meeting at Booth #418, to be held from May 19-23 at Washington State Convention Center, Seattle, WA. INTA’s (International Trademark Association) Annual Meeting is recognized as one of the premier events for the trademark industry which is expected to attract more than 10,000 attendees from around the world. Brand owners, in-house counsel, law firms, government officials, and other IP experts will gather in this 140th annual meeting to discuss and examine the key industry issues, challenges, and opportunities in the ever-growing IP landscape. MaxVal, a preferred IP management partner for law firms and

Continue reading »